Essential Role of Histone Methyltransferase G9a in Rapid Tolerance to the Anxiolytic Effects of Ethanol

Int J Neuropsychopharmacol. 2019 Apr 1;22(4):292-302. doi: 10.1093/ijnp/pyy102.

Abstract

Background: Tolerance to ethanol-induced anxiolysis promotes alcohol intake, thus contributing to alcohol use disorder development. Recent studies implicate histone deacetylase-mediated histone H3K9 deacetylation in regulating neuropeptide Y expression during rapid ethanol tolerance to the anxiolytic effects of ethanol. Furthermore, the histone methyltransferase, G9a, and G9a-mediated H3K9 dimethylation (H3K9me2) have recently emerged as regulators of addiction and anxiety; however, their role in rapid ethanol tolerance is unknown. Therefore, we investigated the role of G9a-mediated H3K9me2 in neuropeptide Y expression during rapid ethanol tolerance.

Methods: Adult male rats were administered one injection of n-saline followed by single acute ethanol injection (1 g/kg) 24 hours later (ethanol group) or 2 injections (24 hours apart) of either n-saline (saline group) or ethanol (tolerance group). Anxiety-like behaviors and global and Npy-specific G9a and H3K9me2 levels in the amygdala were measured. Effects of G9a inhibitor (UNC0642) treatment on behavioral and epigenetic measures were also examined.

Results: Acute ethanol produced anxiolysis and decreased global H3K9me2 and G9a protein levels in the central and medial nucleus of the amygdala as well as decreased occupancy levels of H3K9me2 and G9a near a putative binding site for cAMP-response element binding protein on the Npy gene. Two identical doses of ethanol produced no behavioral or epigenetic changes relative to controls, indicating development of rapid ethanol tolerance. Interestingly, treatment with UNC0642, before the second ethanol dose reversed rapid ethanol tolerance, decreased global H3K9me2 and increased neuropeptide Y levels in the central and medial nucleus of the amygdala.

Conclusions: These results implicate amygdaloid G9a-mediated H3K9me2 mechanisms in regulating rapid tolerance to the anxiolytic effects of ethanol via neuropeptide Y expression regulation.

Keywords: G9a; alcohol use disorder; amygdala; anxiety; rapid ethanol tolerance.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amygdala* / drug effects
  • Amygdala* / metabolism
  • Animals
  • Anti-Anxiety Agents / administration & dosage
  • Anti-Anxiety Agents / pharmacology*
  • Anxiety / drug therapy*
  • Behavior, Animal / drug effects
  • Disease Models, Animal
  • Drug Tolerance*
  • Epigenesis, Genetic / drug effects
  • Ethanol / administration & dosage
  • Ethanol / pharmacology*
  • Gene Expression Regulation / drug effects
  • Histone-Lysine N-Methyltransferase* / antagonists & inhibitors
  • Histone-Lysine N-Methyltransferase* / drug effects
  • Histone-Lysine N-Methyltransferase* / metabolism
  • Male
  • Neuropeptide Y* / drug effects
  • Neuropeptide Y* / metabolism
  • Quinazolines / pharmacology
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Anti-Anxiety Agents
  • Neuropeptide Y
  • Quinazolines
  • UNC0642
  • Ethanol
  • Ehmt2 protein, rat
  • Histone-Lysine N-Methyltransferase